Oct 2016 $10 M No. 5 $10 to $50 million 16
DermTech International: Raise no. 5, Oct 2016 × Investors in this round 16 investors had bought by the notice of Feb 7, 2018: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $16 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions $445,667
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gary Jacobs · Executive Officer, Director John Dobak, M.D. · Executive Officer, Director Steven Kemper · Executive Officer Carl Peck, M.D. · Director Gene Salkind, M.D. · Director Scott Pancoast · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Paulson Investment Company LLC (CRD 5670) · Portland, Oregon Sold in all US states Signed by John Dobak, M.D., President & CEO. Source: SEC Form D and 4 amendments, newest notice filed Feb 7, 2018. Read the notice at the SEC .
equity, options SEC Jul 2015 $4 M No. 4 $2 to $10 million 8
DermTech International: Raise no. 4, Jul 2015 × Investors in this round 8 investors had bought by the notice of Nov 12, 2015: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $20 M offered; $16 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $560,933
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Gary Jacobs · Executive Officer, Director John Dobak, M.D. · Executive Officer, Director Michael Willis · Executive Officer Steven Kemper · Executive Officer Carl Peck, M.D. · Director Gene Salkind, M.D. · Director Scott Pancoast · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Paulson Investment Company LLC (CRD 5670) · Portland, Oregon Sold in all US states Signed by John Dobak, M.D., President & CEO. Source: SEC Form D and 1 amendment, newest notice filed Nov 12, 2015. Read the notice at the SEC .
equity, options SEC Apr 2015 $2 M No. 3 $2 to $10 million 16
DermTech International: Raise no. 3, Apr 2015 × Investors in this round 16 investors had bought by the notice of Apr 15, 2015: 16 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gary Jacobs · Executive Officer, Director John Dobak, M.D. · Executive Officer, Director Michael Willis · Executive Officer Steven Kemper · Executive Officer Carl Peck, M.D. · Director Gene Salkind, M.D. · Director Scott Pancoast · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Dobak, M.D., President & CEO. Source: SEC Form D, newest notice filed Apr 15, 2015. Read the notice at the SEC .
debt, options SEC Aug 2013 $6 M No. 2 $2 to $10 million 30
DermTech International: Raise no. 2, Aug 2013 × Investors in this round 30 investors had bought by the notice of Aug 16, 2013: 30 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $9 M offered; $4 M still to sell
Smallest investment taken $25,000
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Gary Jacobs · Executive Officer, Director John Dobak, M.D. · Executive Officer, Director Carl Peck, M.D. · Director Gene Salkind, M.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Of the $5,774,985 Total Amount Sold, $2,429,999 is new money and $3,344,986 is the conversion of outstanding convertible notes or debt. Total Offering Amount includes shares issuable upon exercise of warrants issued in connection with financing.”Signed by John Dobak, M.D., President & CEO. Source: SEC Form D, newest notice filed Aug 16, 2013. Read the notice at the SEC .
equity, options SEC Mar 2008 $11 M No. 1 $10 to $50 million 15
DermTech International: Raise no. 1, Mar 2008 × Investors in this round 15 investors had bought by the notice of Apr 11, 2012: 15 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $12 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in California People named in the notice Gary Jacobs · Executive Officer, Director · President Carl Peck, M.D. · Director Gene Salkind, M.D. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Gary Jacobs, President. Source: SEC Form D, newest notice filed Apr 11, 2012. Read the notice at the SEC .
equity, debt, options SEC